Myomo Inc (MYO)

Currency in USD
0.900
-0.019(-2.05%)
Real-time Data·
MYO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.8700.940
52 wk Range
0.6051.885
Key Statistics
Prev. Close
0.919
Open
0.94
Day's Range
0.87-0.94
52 wk Range
0.605-1.885
Volume
122.49K
Average Volume (3m)
372.75K
1-Year Change
24.9306%
Book Value / Share
0.069
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MYO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.640
Upside
+415.56%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Myomo Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.640
(+415.56% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Craig-Hallum
Buy1.10+22.22%2.00Maintain10-03-2026

Myomo Inc Earnings Call Summary for Q3/2026

  • Myomo posted record Q3 revenue of $12.3M, up 22% YoY and beating estimates, though EPS loss of $0.10 missed forecasts by $0.02.
  • Gross margin expanded 750 bps to 71.3%; adjusted EBITDA reached breakeven vs. $2.7M loss last year, showing progress toward profitability.
  • Company narrowed FY2026 revenue guidance to $46M-$47M from $45M-$47M; expects Q4 cash burn under $500K and full H2 burn below $2M.
  • Recurring patient revenue from rehab facilities and VA rose to 54% of sales from 33% YoY, strengthening business model durability.
  • Shares rose 15.7% in regular trading to $1.40 but slipped 5% after-hours to $1.33 as investors weighed the EPS miss against strong revenue trends.
Last Updated: 10-11-2026, 03:52 am
Read Full Transcript

Earnings

Latest Release
09-11-2026
EPS / Forecast
-0.10 / -0.08
Revenue / Forecast
12.3M / 11.37M
EPS Revisions
Last 90 days

MYO Income Statement

Compare MYO to Peers and Sector

Metrics to compare
MYO
Peers
Sector
Relationship
P/E Ratio
−2.4x−0.3x−0.2x
PEG Ratio
0.12−0.050.00
Price/Book
13.4x1.9x2.6x
Price / LTM Sales
0.8x3.1x2.7x
Upside (Analyst Target)
-159.0%68.5%
Fair Value Upside
Unlock−7.0%11.5%Unlock

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran’s administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.43M6.13%2.48M
Other Institutional Investors
20.56M51.90%20.97M
Public Companies & Retail Investors
16.62M41.97%16.96M
Total
39.61M100.00%40.4M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rosalind Advisors, Inc.9.18%36,37,8863,711
Rosalind Master Fund L.P.9.18%36,37,8863,711

FAQ

What Is the Myomo (MYO) Share Price Today?

The Myomo share price today is 0.900.

What is the current Myomo (MYO) share price and day range?

As of 18-11-2026, the Myomo share price is 0.900, with a previous close of 0.919. The share price has ranged from 0.870 to 0.940 today, while the 52-week range spans from 0.605 to 1.885.

What Is the Myomo Market Cap?

As of today, Myomo market cap is 36.090M.

What Is the Myomo (MYO) Share Price Target?

The average 12-month share price target for Myomo is 4.640, with a high estimate of 10.5 and a low estimate of 1.7. 5 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +415.56% Upside potential.

What Is Myomo's Earnings Per Share (TTM)?

The Myomo EPS (TTM) is -0.35.

When Is the Next Myomo Earnings Date?

Myomo will release its next earnings report on 10-03-2027.

From a Technical Analysis Perspective, Is MYO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Myomo Trade On?

Myomo is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Myomo?

The stock symbol for Myomo is "MYO."

How Many Times Has Myomo Stock Split?

Myomo has split 1 times.

How Many Employees Does Myomo Have?

Myomo has 195 employees.

What Is the MYO Premarket Price?

MYO's last pre-market stock price is 0.950. The pre-market share volume is 4,040.000, and the stock has changed by 0.031, or 3.370%.

What Is the MYO After Hours Price?

MYO's last after hours stock price is 0.931, the stock has changed by 0.012, or 1.330%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.